Phase III Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as rst-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer: a Multicentre, Open-label, Randomised Study
Phase of Trial: Phase III
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Erlotinib (Primary)
- Indications Brain metastases; Non-small cell lung cancer
- Focus Pharmacogenomic; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 24 Aug 2016 Status changed from recruiting to completed.
- 23 Sep 2013 Planned number of patients changed from 208 to 224 as reported by ClinicalTrials.gov.